Neuroscience News and Research

RSS

Research: DBS may provide therapeutic relief to binge eating

Deep brain stimulation in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.

24 Apr 2013

fMRI study shows unique brain regions are devoted to social self-evaluations during puberty

A specific region of the brain is in play when children consider their identity and social status as they transition into adolescence -- that often-turbulent time of reaching puberty and entering middle school, says a University of Oregon psychologist.

24 Apr 2013

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.

24 Apr 2013

Psychedelics continue to be widely used in US, researchers say

In their article "Over 30 million psychedelic users in the United States", Teri S Krebs and P-l--rjan Johansen from the Department of Neuroscience at Norwegian University of Science and Technology, use data from a randomly-selected sample of over 57,000 individuals surveyed for the 2010 National Survey on Drug Use and Health, to estimate lifetime prevalence of psychedelic use.

24 Apr 2013

Animal models of Huntington's disease allow better insights into disease's genetics

Scientific progress in Huntington's disease (HD) relies upon the availability of appropriate animal models that enable insights into the disease's genetics and/or pathophysiology.

23 Apr 2013

Biological Psychiatry special issue tackles the question on food addiction

Biological Psychiatry is proud to announce this week's publication of a special issue focusing on the question of food as an addiction.

23 Apr 2013

International team of researchers joins forces to decode genome of prehistoric fish

An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code.

22 Apr 2013

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.

22 Apr 2013

Janssen Diabetes Forum: A medical education initiative for management of type 2 diabetes

Launched today in Beerse, the Janssen Diabetes Forum (www.janssendiabetesforum.com) is a novel medical education initiative, which has been developed to contribute to the understanding of the latest developments in the management of type 2 diabetes.

22 Apr 2013

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.

22 Apr 2013

Advanced microscope reveals process where mutations lead to autism and other diseases

Using spinning disk microscopy on barely day-old zebra fish embryos, University of Oregon scientists have gained a new window on how synapse-building components move to worksites in the central nervous system.

22 Apr 2013

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

MR-guided focused ultrasound is a new technique that involves focusing 1024 beams of ultrasound through the skull to a focal point in the brain, very much like using the sun and a magnifying glass to burn a hole in a sheet of paper.

22 Apr 2013

Study: Stem cell transplant heals neurological deficits in mice

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

22 Apr 2013

3-D brain images provide a better understanding on migraine attack

Wielding a joystick and wearing special glasses, pain researcher Alexandre DaSilva rotates and slices apart a large, colorful, 3-D brain floating in space before him.

22 Apr 2013

Research reveals how three-dimensional, volumetric, space is perceived in mammalian brains

Animals navigate and orient themselves to survive - to find food and shelter or avoid predators, for example. Research conducted by Dr. Nachum Ulanovsky and research student Michael Yartsev of the Weizmann Institute's Neurobiology Department, published today in Science, reveals for the first time how three-dimensional, volumetric, space is perceived in mammalian brains.

22 Apr 2013

Study shows how brain mobilizes to track down person, animal or thing

A contact lens on the bathroom floor, an escaped hamster in the backyard, a car key in a bed of gravel: How are we able to focus so sharply to find that proverbial needle in a haystack? Scientists at the University of California, Berkeley, have discovered that when we embark on a targeted search, various visual and non-visual regions of the brain mobilize to track down a person, animal or thing.

22 Apr 2013

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.

20 Apr 2013

$Study: Primary medication nonadherence can lead to increased risk of bone fractures$

Study: Primary medication nonadherence can lead to increased risk of bone fractures

Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International.

19 Apr 2013

Excess glutamate drives schizophrenia in high-risk individuals

An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a study from investigators at Columbia University Medical Center published in the current issue of Neuron.

19 Apr 2013

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

The bombs at the Boston Marathon were designed to maim and kill, and they did. Three people died within the first moments of the blast. More than a hundred and seventy people were injured. They had their limbs blown off, vital arteries severed, bones fractured, flesh torn open by shrapnel or scorched by the blasts' heat. Yet it now appears that every one of the wounded alive when rescuers reached them will survive.

19 Apr 2013

Neuroscience News and Research

Research: DBS may provide therapeutic relief to binge eating

fMRI study shows unique brain regions are devoted to social self-evaluations during puberty

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Psychedelics continue to be widely used in US, researchers say

Animal models of Huntington's disease allow better insights into disease's genetics

Biological Psychiatry special issue tackles the question on food addiction

International team of researchers joins forces to decode genome of prehistoric fish

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Janssen Diabetes Forum: A medical education initiative for management of type 2 diabetes

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Advanced microscope reveals process where mutations lead to autism and other diseases

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Study: Stem cell transplant heals neurological deficits in mice

3-D brain images provide a better understanding on migraine attack

Research reveals how three-dimensional, volumetric, space is perceived in mammalian brains

Study shows how brain mobilizes to track down person, animal or thing

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Study: Primary medication nonadherence can lead to increased risk of bone fractures

Excess glutamate drives schizophrenia in high-risk individuals

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News